Background/Aims. The fate of intrahepatic NK cell subsets in the course of HCV and HBV infections is not clearly understood.
Introduction:
Hepatitis C virus (HCV) and hepatitis B virus (HBV) are preferentially hepatotropic, not directly cytopathic, capable of provoking acute and chronic necro-inflammatory liver injury and are the most common causes of liver disease worldwide [1] The various strategies that many viruses have evolved to evade natural killer (NK) cell effector functions illustrate the central role for these cells in early host defense against viral infections [2, 3] . It is known that both HCV and HBV, impair human and murine NK cell activity [4, 5] . HCV may inhibit the activation of Interferon Regulatory Factor (IRF) [6] and can interfere with PKR kinase function [7] which can activate NK cells. In the case of HBV, both IRF and PKR appear to mediate signals that modulate viral replication in IRF( -/-) or PKR( -/-) transgenic mice [8] . In contrast to other viruses, HCV and HBV induce sustained HLA class I expression on infected cells [9, 10] . The inhibitory effect of NK cells on HCV replication in cultured human hepatocytes [11] suggests that NK cells might be able to contribute to the control of these infections. In the early phase of HBV infection, the host's response to HBV mediates the activation of NK cells which produce IFN-α and are able to lyse infected cells by TRAIL-mediated death of hepatocytes [12] .
Despite multiple studies on the functional potential of NK cells in persistent HCV and HBV infections [13] [14] [15] , evidence of a role for NK cell defects in these chronic infections remains open for debate. It is established that NK cell frequencies in HCVinfected patients are lower than those observed in the un-infected population [14] [15] [16] . According to the surface expression level of CD56, NK cells can be divided into two subsets with important functional distinctions. The vast majority of NK cells displays a moderate level of CD56 (CD56 dim ) with a marked cytotoxicity potential, while, a small proportion harbors a high CD56 expression level (CD56 bright ) having a greater capacity to secrete cytokines [17, 18] . Recently, it was reported that the frequency of peripheral blood cytolytic CD56 dim NK cells is decreased in HCV infected patients [15] . Less is known about expression of HLA class I specific NK receptors (NKRs). NKRs are subdivided into two major families. The first family is composed of killer immunoglobulin-like receptors (KIR), such as CD158 molecules and LIR1/ILT2 (leukocyte Ig-like receptor 1/Ig-like transcript 2) which recognize classical HLA-A, -B and -C class I molecules. The second family includes C type lectin-like molecules, such as, NKG2A that associate with CD94 to form inhibitory heterodimer that recognize non-classical HLA-E molecules. .
Here, we have performed flow cytometry analyses and detailed histological studies on liver biopsies to quantify and localize the CD56 + cells in the different histological areas. Furthermore we investigated the perforin contents of different NK cells subset as markers of their cytotoxicity. Then, we searched for relationship between NK cells subset distribution and the clinical parameters.
Materials and Methods

Patients.
Chronic hepatitis C (n=28) and B patients (n=19) seen in the Grenoble University Hospital between 2005 and 2007, were included in this study. Their main characteristics were analyzed as previously described [19] and are summarised in Table 1 . For immunohistochemical studies, HCV (n=6) and HBV patients (n=6) patients were classed as have low necro-inflammatory grading (Metavir-A1, 3 patients) and high necroinflammatory grading (Metavir-A3, 3 patients) by the French Metavir Scoring System. Blood samples from healthy volunteers (n=18) were obtained from the regional Etablissement Français du Sang (La Tronche, France).
Isolation of intra-hepatic cells.
Liver biopsies obtained by using 1.5 mm diameter disposable biopsy needle were processed for histopathological examination and immunological analysis. Cells were prepared as described previously [20, 21] . Monoclonal antibodies, Immunostaining and Flow Cytometry.
The monoclonal antibodies used were anti-CD3 PC7 (UCHT1), anti-CD56 PE (NCAM16.2), and anti-Perforin FITCconjugated (δG9), from Becton-Dickinson Biosciences (Pont de Claix, France). AntiCD158a,h+-PE (EB6), anti-CD158b1,b2,j-PE (GL183), anti-NKG2A(CD159A)-PE (Z199) were obtained from Beckman Coulter France (Villepinte, France). Immunostaining and flow cytometric analysis were done as described previously [19, 22] [20] . Several parameters were scored separately including total lymphocytes, CD56 + cells, and association of CD56 + cells with piece meal necrosis or lobular necrosis as well as their localization in the fibrotic tissues and in the nodular parenchyma. The numbers of cells were expressed as Unit defined as 40 fields (400X) equivalent of an area of 2.74 mm 2 . For double immunostaining, antigen retrieval was performed with CC1 basic buffer pre-treatment for 60 minutes, followed by incubation with the primary anti-CD56 antibody and detected with Ultra-View Diaminobenzidine multimer kit. For CD3 detection, a second CC1 pre-treatment was applied on the same slides followed by incubation with the primary antibody (polyclonal rabbit CD3, 1/100, Dako A0452) incubation with a secondary antibody (biotinylated goat anti-rabbit IgG, 1/750, Jackson Immunoresearch 111-065-003) was detected with Ultra-View Alkalin Phosphatase red multimer kit and counterstaining (Conterstain 2) for 5 minutes.
The non-parametric Wilcoxon, Spearman and Mann-Whitney U-tests were performed for comparisons between the groups of patients and controls as previously described [19] .
Results
Decreased frequency of blood and intra-hepatic NK cells in HCV patients.
The flow cytometric gating strategy used to identify the different subsets of NK cells is depicted in Fig.1 
Intrahepatic localization of CD56
+ cells in HCV and HBV patients.
In order to precisely quantify and localise CD56 + cells in different intra-hepatic areas (nodular parenchymatous areas and necroinflammatory lesions) immunohistochemistry was performed. We selected 6 chronic HCV patients with A1 (n=3) and A3 (n=3) Metavir scores and 6 chronic histologically-matched HBV patients. The presence of CD56 + cells was detected essentially in piecemeal and lobular necrosis (Fig.3 A, B, C, D) . CD56 + cell density were significantly lower in the liver of HCV patients compared to HBV patients (69 vs134 -p<0.05) (Fig.3E) (Fig.3F) ; and ii) CD56 + cell density was low inside the necro-inflammatory lesions (piecemeal necrosis and lobular necrosis) in both HCV and HBV patients. However, inside the necro-inflammatory lesions, CD56 + cells were significantly higher in HCV patients as compared to HBV patients (9 vs 2, p<0.005) (Fig.3G) .
In some cases, double immunostaining of CD56 and CD3 cells was investigated in order to distinguish between classical NK cells (CD3   -CD56 + ) and cells expressing CD3 and CD56 molecules.
We observed numerous CD3 + lymphocytes (red, Fig.3H,I ) and few CD56 + cells (brown, Fig.3H,I ) present in the fibrous areas and in necro-inflammatory lesions. Orange CD56/CD3 double-stained cells were scarce and observed in the fibrous septa only (Fig.3H) .
Relationship between blood and intra-hepatic CD3 -CD56 + NK cells in necro-inflammatory lesions
In both HCV and HBV infection, intrahepatic CD56 + cells density remained constant whatever the necro-inflammatory grading (Fig.3) . In contrast, the CD56 -cell density increased from A1 to A3 Metavir score, in both HCV and HBV patients (Table 2) . Thus, the proportion of CD56 + cells among total lymphocytes decreased from A1 to A3 Metavir in both HCV and HBV groups. The CD56 + cell density inside the necro-inflammatory lesions was higher in Metavir-A1 than in Metavir-A3 patients in HCV groups but such difference was not found in HBV groups. With increasing necro-inflammatory activity, CD56
+ cells tended to localize preferentially outside of necroinflammatory lesions in HCV patients. In both groups, peripheral CD3 -CD56 + NK cells did not correlate with any bioclinical parameters including necro-inflammatory grade, ALT serum levels and viral load.
Analysis of HLA class I specific receptors expression by NK cells.
Among blood NK cells, expression of CD158a/h, CD158b/j and NKG2A did not differ between HCV patients and healthy donors. However, we detected a significant decrease of NKG2A + expression in HBV patients as compare to HCV patients (54.5% vs 24.7%, p<0.001) and healthy donors (55.4% vs 24.7 %, p<0.001) (Fig.4A) . (Fig.4B,C) , whereas NKG2A + NK cell frequency was comparable in liver and blood NK cells (58.0% vs 54.5%, NS) (Fig.4A) . In contrast, in the liver of HBV patients, the frequency of CD158a,h + , CD158b,j + and NKG2A NK cells appeared similar to those observed in the blood (mean values: 26.3% vs 27.5% -NS, 30.9% vs 28.6% -NS, 24.7% vs 26.1% -NS, respectively) (Fig.4B,C) .
In HCV patients, the frequency of intrahepatic CD158a,h + and CD158b,j + NK cells appeared significantly lower than those observed in HBV patients (7.6% vs 27.5%, p<0.001 and 15.0% vs 28.6% -p<0.005 respectively). Inversely, the frequency of intra-hepatic NKG2A + NK cells was significantly higher in HCV than in HBV patients (58% vs 26.1% -p<0.005). Taken together, our findings revealed striking modifications in the tissue distribution of these NK cell subsets in patients with persistent HCV or HBV infection, in particular: i) reduced proportions of CD158a,h + and CD158b,j + liver infiltrating NK lymphocytes among HCV patients, at different stages of the viral infections, even in patients with low Metavir Activity score (data not shown) and, ii) alterations in intra-hepatic NKG2A + NK cells in HBV patients (Fig.4A) .
Analysis of perforin expression among intrahepatic CD3
-CD56 + NK cells. To provide further insights in the potential cytotoxicity of NK cells, we studied the cellular contents of perforin in intra-hepatic CD56 + cells of 5 HCV patients and 2 HBV patients. In HCV patients, 67.43 ± 6.09% of CD3 -CD56 + cells were perforin positive (Fig.1F) , suggesting that a large amount of CD56 + cells showed a cytotoxic potential. As in HCV patients, NKG2A
+ cells represented the major subset of CD3 -CD56 + NK cells, we investigated their perforin content. 83.77 ± 45.36% of these cells were perforin positive (Fig.1G) indicating that the subset of NK cells expressing NKG2A marker had the cytolytic potential in HCV infected patients. Interestingly, the same analysis conducted on HBV patients revealed that only 35.48 ± 22.17% of CD3 -CD56 + cells were perforin positive. The low frequency of CD3 -CD56 + NKG2A + in HBV patients impedes accurate quantification perforin-expressing cells. In parallel, in HCV patients, the analysis of intra-hepatic cells selected for the expression CD3 + CD56 + and perforin revealed that the proportion of perforin positive cells was low (less than 10 %). These results were in agreement with our previous report indicating that the proportion of perforin positive cells among blood CD3 + CD56 + T cells was reduced in HCV patients (Fig.1H) [19] . + ) The frequency of (A) NKG2A + , (B) CD158a,h + and (C) CD158b,j + cells within the total NK cells population (CD3 -CD56 + ) was analyzed in blood lymphocytes for healthy control, HCV + and HBV + patients and in intra-hepatic lymphocytes for HCV + and HBV + patients by the flow cytometry.
Metavir
Analysis of the frequencies of CD3
-CD56 + NK cells subsets with clinical parameters in HCV and HBV patients.
First, we analyzed the correlation between intra-hepatic and peripheral CD3 -
CD56
+ cells according to activity or fibrosis in HCV or HBV infected patients. In HCV patients, negative correlations were observed between intra-hepatic CD3 -CD56 + cells and Metavir Activity (r= -0.579, p=0.006) or Metavir Fibrosis (r= -0.547, p=0.010). More specifically, the frequencies of intra-hepatic CD3 -CD56 + cells decreased with increased Metavir activity (Fig.5A) (A1/A3-z=-2.386-p=0 .016 or A2/A3-z=-2.148-p=0.030) and Metavir fibrosis scores (Fig.5B) (F0/F2, z=-1.890, p=0.073) . Such correlations were not observed in peripheral cells in HCV patients and in peripheral or intrahepatic cells in HBV patients. 
bright NKG2A + cells increased also with the severity of disease in these patients. Indeed, positive correlations were observed between these peripheral cells and Activity (A1/A3-z=2.550;p=0.008 and A2/A3-z=2.472; p=0.011) (Fig.5C ) and also with fibrosis (F1/F3-z=1.927; p=0.052 and F1/F4-z=1.974; p=0.051) (Fig.5D) . It is important to note that the correlations mentioned above between the subsets of NK cells and severity of disease, were not found in the case of HBV patients. Concerning HCV patients, we observed a negative association (r = -0.540, p<0.01) between the frequency of CD3 -
+ NKG2A + cells and the serum viral load (Fig.6A ). This comparable negative correlation was also detectable in these patients when the analysis was restricted to the blood CD3   -CD56 dim subset (r = -0.441, p<0.05 (Fig.6B) . In HBV infected patients, we did not observe any correlation between viral load and peripheral NK cell subsets. However, in the six HBV infected patients in whom viral load and intrahepatic flow cytometric data were available, a negative correlation between CD3 -CD56
+ and viral load (r=-0.900-p<0.05) was found. 
Discussion
Ours data confirm a significant reduction in NK cell frequency and a quantitative imbalance of the CD56 bright and CD56 dim subsets within the total NK cell population in HCV and HBV infected patients [14, 16] [29] . One can argue that under constant HCV-mediated inhibition combined to cell-cell interaction(s) and/or local cytokine production a level of selective persistence/retention of specific intra-hepatic NK cell subsets lose the ability to undergo differentiation beyond the CD3 -CD56 bright stage but acquire higher cytotoxic activity.
This hypothesis is supported by our data showing that the frequency of intra-hepatic CD3 -
CD56
+ Perforin + cells in HCV patients is higher than the equivalent counterpart in HBV patients. In summary, our analysis indicates that a high necro-inflammatory activity score is associated to a high frequency of CD3 -CD56 
